Open access
Plasma Proteomic Signatures for Early Risk Stratification Across Cardiovascular‐Kidney‐Metabolic Stages 0–2
Xing-Yu Li
Hong-Qiang Zhang
Sui-Jian Wang
Jie Shi
Jun-Hao Zhang
Ming-Hui Chen
Min-Zhe Zhao
T. Yue
X. Zheng
Sep 2026 · Diabetes, obesity and metabolism · Vol 28, pp. 11901 - 11914 · 0 citations
· 33 references
Medicine
Abstract
Cardiovascular‐kidney‐metabolic (CKM) stages 0–2 represent a potentially modifiable period before overt cardiovascular complications, yet molecular markers that identify individuals at higher downstream risk remain insufficiently defined. We investigated whether plasma proteomic signatures could characterize early CKM‐related molecular risk and improve prediction of incident cardiovascular, kidney and mortality outcomes.